SCHEMBL1992334

SCHEMBL1992334

CC(C)(Oc1ccc(F)cc1-c1ccc(S(=O)(=O)c2ccccc2F)c(F)c1)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ACLY P53396 2/20 0.37
PTGDR2 Q9Y5Y4 3/20 0.37
PPARA Q07869 3/20 0.35
PPARG P37231 2/20 0.35
PPARD Q03181 2/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2351027 0.87 GRM5 (0.39) KDM4EALDH1A1HSD17B10ACLYPTGDR2
SCHEMBL1989516 0.83 PTGS2 (0.47) ALDH1A1ACLYHTR2AHTR2CKCNH2
SCHEMBL1990082 0.82 ABCB11 (0.49) ALDH1A1PTGDR2PPARAPPARGPPARD
SCHEMBL1989829 0.81 ABCC9 (0.43) KDM4EALDH1A1HSD17B10ACLYPTGDR2
SCHEMBL1992333 0.79 PPARG (0.40) ACLYPTGDR2PPARAPPARGPPARD
SCHEMBL1992331 0.78 ABCB11 (0.39) ALDH1A1ACLYPTGDR2HTR2AHTR2C
SCHEMBL1996020 0.76 HTR2A (0.43) KDM4EALDH1A1HSD17B10ACLYMEN1
SCHEMBL2347649 0.75 PTGDR2 (0.40) PTGDR2ALOX5APFEN1FFAR4
SCHEMBL1989553 0.75 HTR6 (0.51) KDM4EALDH1A1ACLYMEN1KMT2A
SCHEMBL1998315 0.74 NR3C1 (0.49) ACLYHTR2AHTR2CKCNH2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008350-B2 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease ASTRAZENECA AB (SE) 2011-08-30 US disclosed
US-20110152374-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease ASTRAZENECA AB (SE) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152374-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease BPGM, PPARA, HPD KDM4E 1829/4885ALDH1A1 224/4885HSD17B10 638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.